COVID-19 therapy: corticosteroids including dexamethasone and hydrocortisone

In accordance with World Health Organization (WHO) recommendations, systemic corticosteroids should be used in patients with severe and critical COVID-19 disease, but not in patients with non-severe COVID-19.

Click here to view further detail of the recommendation on systemic corticosteroids and COVID-19.

Medical staff should follow this guidance in the management of COVID-19. Hospital clinical pharmacists should ensure prescribing guidance is followed.